DNA MODIFYING ENZYMES AND ACTIVE FRAGMENTS AND VARIANTS THEREOF AND METHODS OF USE

Systems targeting PSMA and CA9

CRISPR INDUCED DISRUPTION OF MOGS GENE

CRISPR/CAS9-BASED COMPOSITIONS AND METHODS FOR TREATING RETINAL DEGENERATIONS

COMPOSITIONS AND METHODS FOR INHIBITING THE EXPRESSION OF TMIGD2

DNA modifying enzymes and active fragments and variants thereof and methods of use

CLASS II, TYPE V CRISPR SYSTEMS

COMPOSITIONS AND METHODS FOR SITE-DIRECTED MUTAGENESIS

EPIGENETIC MODULATORS FOR TISSUE REPROGRAMMING

A METHOD FOR IN VIVO GENE THERAPY TO CURE SCD WITHOUT MYELOABLATIVE TOXICITY

COMPOSITIONS AND METHODS FOR THE TREATMENT OF SPINAL MUSCULAR ATROPHY (SMA)

MODIFIED ORGANS AND TISSUES

SYSTEMS AND METHODS FOR THE TREATMENT OF HEMOGLOBINOPATHIES

SINGLE CELL CHROMATIN IMMUNOPRECIPITATION SEQUENCING ASSAY

REGULATION OF CELLS AND ORGANISMS

METHODS AND COMPOSITIONS FOR PRIME EDITING NUCLEOTIDE SEQUENCES

SYSTEMS AND METHODS FOR TRANSPOSING CARGO NUCLEOTIDE SEQUENCES

Methods of Treating Rheumatoid Arthritis Using RNA-Guided Genome Editing of HLA Gene

CYTIDINE DEAMINASES AND METHODS OF GENOME EDITING USING THE SAME

MODIFICATION OF BRASSINOSTEROID RECEPTOR GENES TO IMPROVE YIELD TRAITS

COMPOSITIONS AND METHODS COMPRISING PLANTS WITH REDUCED RAFFINOSE FAMILY OLIGOSACCHARIDES AND/OR HIGH PROTEIN CONTENT

METHODS AND COMPOSITIONS FOR REDUCING POLYPHENOL OXIDASE ACTIVITY IN PLANTS

COMPOSITIONS AND METHODS COMPRISING PLANTS WITH MODIFIED SEED PROTEIN AND/OR OIL CONTENT

DOUBLE DECAPITATION OF PLANTS

SYSTEMS AND METHODS FOR AN INTRANASAL DRUG DELIVERY SYSTEM

TARGET SEQUENCE SPECIFIC ALTERATION TECHNOLOGY USING NUCLEOTIDE TARGET RECOGNITION

COMPOSITIONS AND METHODS FOR IMPROVING T CELL PERSISTENCE AND FUNCTION

ADAR SPECIFIC GUIDE RNAS AND USES THEREOF

CRISPR ENZYMES, METHODS, SYSTEMS AND USES THEREOF

FUSION EFFECTOR PROTEINS AND USES THEREOF

ENGINEERED PROTEINS AND METHODS OF USE THEREOF

EFFECTOR PROTEINS AND METHODS OF USE

CHIMERIC PSEUDOTYPED RECOMBINANT RABIES VIRUS

COMPOSITIONS AND METHODS FOR CELLULAR REPROGRAMMING USING CIRCULAR RNA

DELIVERY OF CAS9 VIA ARRDC1-MEDIATED MICROVESICLES (ARMMS)

PROGRAMMABLE NUCLEASE DIAGNOSTIC DEVICE

TREATING DISEASES AND IMPROVING NUCLEIC ACID DELIVERY

MODIFIED IMMUNE CELLS AND METHODS OF USING THE SAME

GENOMIC EDITING OF RBM20 MUTATIONS

CHIMERIC ANTIGEN RECEPTOR TO TARGET TROP-2-POSITIVE CANCERS

LIPID NANOPARTICLE COMPOSITIONS FOR DELIVERY OF MRNA AND LONG NUCLEIC ACIDS

RNASE H2 MUTANTS THAT REDUCE PRIMER DIMERS AND OFF-TARGET AMPLIFICATION IN RHPCR-BASED AMPLICON SEQUENCING WITH HIGH-FIDELITY DNA POLYMERASES

STRATEGIES TO DEVELOP GENOME EDITING SPHERICAL NUCLEIC ACIDS (SNAS)

ENGINEERED NODAVIRAL CARGO DELIVERY SYSTEMS

COMPOSITIONS AND METHODS FOR GENE EDITING

Method for the Generation of Genome Edited Protoplasts from Clonally Propagated Plant Tissue

METHODS AND COMPOSITIONS FOR MODULATING A GENOME

TYPE I-B CRISPR-ASSOCIATED TRANSPOSASE SYSTEMS

NUCLEIC ACID-GUIDED NICKASES

GENE THERAPY FOR THE TREATMENT OF SEVERE COMBINED IMMUNODEFICIENCY (SCID) RELATED TO RAG1

METHOD FOR PRODUCING DIRECTLY REPROGRAMMED NATURAL KILLER CELLS AND USES THEREOF

Cell line for TCR discovery and engineering and methods of use thereof

NUCLEIC ACIDS ENCODING ANCHOR MODIFIED ANTIBODIES AND USES THEREOF

Hybrid Recombinant Adeno-Associated Virus Serotype Between AAV9 and AAVrh74 with Reduced Liver Tropism

BICISTRONIC CONSTRUCTS FOR ALLOGENEIC GENE THERAPY

ALTERED EXPRESSION OF Y CHROMOSOME-LINKED ANTIGENS IN HYPOIMMUNOGENIC CELLS

Compositions and Methods for Gene Editing in T Cells Using CRISPR/Cpf1

METHODS FOR GENERATING PRIMARY IMMUNE CELLS

TRANSCRIPTION ACTIVATOR-LIKE EFFECTOR NUCLEASES (TALENS) TARGETING HBV

RARE NUCLEIC ACID DETECTION

BASE EDITING ENZYMES

S. PYOGENES CAS9 MUTANT GENES AND POLYPEPTIDES ENCODED BY SAME

HERBICIDE RESISTANT CANNABIS PLANT

METHODS AND COMPOSITIONS FOR SENSITIZATION OF TUMOR CELLS TO IMMUNE THERAPY

NON-RIBOSOMAL SEQUENCE ENRICHMENT AND SINGLE-STRANDED DNA LIBRARY FOR NUCLEIC ACID GUIDED NUCLEASE TARGETING

TRANS-ACTIVATORS AND METHODS AND USE THEREOF

CLASS II, TYPE II CRISPR SYSTEMS

MODIFIED DOUBLE-STRANDED DONOR TEMPLATES

COMPOSITIONS AND METHODS FOR NUCLEIC ACID MODIFICATIONS

SYSTEMS, METHODS, AND COMPOSITIONS COMPRISING MINIATURE CRISPR NUCLEASES FOR GENE EDITING AND PROGRAMMABLE GENE ACTIVATION AND INHIBITION

Fusion Proteins for CRISPR-based Transcriptional Repression

COMPOSITIONS COMPRISING A VARIANT CAS12I4 POLYPEPTIDE AND USES THEREOF

COMPOSITIONS AND METHODS FOR GENE EDITING

COMPOSITIONS AND METHODS FOR THE TARGETING OF C9orf72

RNA expression modulating or editing method via regulation of Cas13 protein

Yeast Single Nucleotide Polymorphisms for Industrially Relevant Phenotypes

THERAPEUTIC GENE SILENCING WITH CRISPR-CAS13

TRANSDUCTION BUFFER

PROTECTED EFFECTOR CELLS AND USE THEREOF FOR ALLOGENEIC ADOPTIVE CELL THERAPIES

EGFR-TARGETING CHIMERIC ANTIGEN RECEPTOR

CYTOKINE ASSOCIATED TUMOR INFILTRATING LYMPHOCYTES COMPOSITIONS AND METHODS

A METHOD FOR IDENTIFYING PEPTIDE THERAPEUTICS TO TREAT A VARIETY OF CONDITIONS

NUCLEASES FOR SIGNAL AMPLIFICATION

GENE EDITING METHOD FOR INHIBITING ABERRANT SPLICING IN STATHMIN 2 (STMN2) TRANSCRIPT

CAS12I2 FUSION MOLECULES AND USES THEREOF

CRISPR-ASSOCIATED TRANSPOSON SYSTEMS AND METHODS OF USING SAME

GENOME EDITING COMPOSITIONS AND METHODS FOR TREATMENT OF CYSTIC FIBROSIS

METHODS AND COMPOSITIONS FOR INSERTION OF ANTIBODY CODING SEQUENCES INTO A SAFE HARBOR LOCUS

MODIFICATION OF BRASSINOSTEROID SIGNALING PATHWAY GENES FOR IMPROVING YIELD TRAITS IN PLANTS

COMPOSITIONS AND METHODS COMPRISING PLANTS WITH INCREASED SEED AMINO ACID CONTENT

MANIPULATED IMMUNOREGULATORY ELEMENT AND IMMUNITY ALTERED THEREBY

GUIDE RNAS FOR CRISPR/CAS EDITING SYSTEMS

METHODS OF MAKING UNBIASED PHAGE LIBRARIES

PROTEIN EXPRESSION

METHODS FOR CONTROLLING MERISTEM SIZE FOR CROP IMPROVEMENT

SYSTEMS AND METHODS FOR CAPTURE OF CIRCULATING FREE DNA

METHOD FOR DIGESTING NUCLEIC ACID IN A SAMPLE

DNA MODIFYING ENZYMES AND ACTIVE FRAGMENTS AND VARIANTS THEREOF AND METHODS OF USE

EFFECTOR PROTEINS AND USES THEREOF

ESTIMATION OF PHENOTYPES USING LARGE-EFFECT EXPRESSION VARIANTS

Polynucleotides, Compositions, and Methods for Genome Editing

CLASS 2 CRISPR/CAS COMPOSITIONS AND METHODS OF USE

CIITA TARGETING ZINC FINGER NUCLEASES

SYSTEMS AND METHODS FOR TRANSPOSING CARGO NUCLEOTIDE SEQUENCES

FANZORS ARE RNA-GUIDED NUCLEASES ENCODED IN EUKARYOTIC GENOMES

TREATMENT FOR HSV-1 USING A MEGANUCLEASE

CRISPR-ASSOCIATED TRANSPOSON SYSTEMS AND METHODS OF USING SAME

POLYPEPTIDE VARIANTS

METHODS OF TREATING MITOCHONDRIAL DISORDERS

INHIBITORS OF DNA-DEPENDENT PROTEIN KINASE AND COMPOSITIONS AND USES THEREOF

NOVEL AAV SEROTYPES DERIVED FROM A LIBRARY SCREEN

ENGINEERED MEGANUCLEASES HAVING SPECIFICITY FOR A RECOGNITION SEQUENCE IN THE HYDROXYACID OXIDASE 1 GENE

Modified Guide RNAs for Gene Editing

GENE EDITING TO IMPROVE JOINT FUNCTION

GENE THERAPY FOR THE TREATMENT OF HYPER-IgE SYNDROME (HIES) BY TARGETED GENE INTEGRATION

TRANSGENIC ANIMALS AND TRANSGENIC EMBRYOS PRODUCING AN ENGINEERED NUCLEASE

CELL-BASED ASSAY FOR QUANTIFYING THE POTENCY AND EFFICACY OF CANNABINOIDS AND/OR TERPENOIDS, AND METHODS OF USE THEREOF

ENDONUCLEASE SYSTEMS

RNA-guided nucleases and active fragments and variants thereof and methods of use

TARGETED DEAMINASE AND BASE EDITING USING SAME

RNA-Guided Human Genome Engineering

METHODS AND COMPOSITIONS FOR MODIFYING SHADE AVOIDANCE IN PLANTS

METHODS AND COMPOSITIONS FOR MODIFYING SHADE AVOIDANCE IN PLANTS

Organelle genome modification using polynucleotide guided endonuclease

COMPOSITIONS AND METHODS FOR TREATING HEPATITIS B VIRUS INFECTION

METHODS AND COMPOSITIONS USING ONE-SIDED TRANSPOSITION

SYSTEMS, METHODS, AND COMPOSITIONS FOR RNA-GUIDED RNA-TARGETING CRISPR EFFECTORS

DNASE FUSION POLYPEPTIDES AND RELATED COMPOSITIONS AND METHODS

ENGINEERED NATURAL KILLER (NK) CELLS AND COMPOSITIONS AND METHODS THEREOF

METHODS OF TREATING MITOCHONDRIAL DISORDERS

ENGINEERED CELLS FOR THERAPY

SYSTEMS AND METHODS FOR PRODUCING PROGENY WITH SELECTIVE TRAITS

METHODS FOR IMPROVING RESISTANCE TO SOYBEAN RUST

METHODS AND SYSTEMS FOR IDENTIFYING TARGET GENES

COMPOSITIONS AND METHODS FOR LARGE-SCALE IN VIVO GENETIC SCREENING

An Isothermal Diagnostic Test that Utilizes a Cas Protein and a Polymerase

METHOD FOR MODIFYING TARGET SITE IN GENOME OF EUKARYOTIC CELL, AND METHOD FOR DETECTING PRESENCE OR ABSENCE OF NUCLEIC ACID SEQUENCE TO BE DETECTED AT TARGET SITE

NOVEL PROCESSES FOR THE PRODUCTION OF OLIGONUCLEOTIDES

GENETIC MODIFICATION

GLOBIN GENE THERAPY FOR TREATING HEMOGLOBINOPATHIES

METHODS AND COMPOSITIONS FOR MODIFYING SHADE AVOIDANCE IN PLANTS

DELAY OR PREVENTION OF BROWNING IN BANANA FRUIT

LIBRARY CONSTRUCTION METHOD BASED ON LONG OVERHANG SEQUENCE LIGATION

Tools and Methods for Mycoplasma Engineering

BIFUNCTIONAL CHEMICAL EPIGENENTIC MODIFIERS AND METHODS OF USE

IMPROVED CYTOSINE TO GUANINE BASE EDITORS

IMPROVED CAS 12A/NLS MEDIATED THERAPEUTIC GENE EDITING PLATFORMS

SYSTEMS, COMPOSITIONS, AND METHODS INVOLVING RETROTRANSPOSONS AND FUNCTIONAL FRAGMENTS THEREOF

ENGRAFTABLE CELL-BASED IMMUNOTHERAPY FOR LONG-TERM DELIVERY OF THERAPEUTIC PROTEINS

METHODS AND MATERIALS FOR TREATING MUSCULAR DYSTROPHY

COMPOSITIONS AND METHODS TO PROGRAM THERAPEUTIC CELLS USING TARGETED NUCLEIC ACID NANOCARRIER

GENETICALLY MODIFIED NK CELLS AND USES THEREOF

METHOD FOR CONTROLLING SLIME IN A PULP OR PAPER MAKING PROCESS

MULTI COLOR WHOLE-GENOME MAPPING AND SEQUENCING IN NANOCHANNEL FOR GENETIC ANALYSIS

CRISPR-CAS12A REACTION FOR RAPID AND HIGHLY SENSITIVE ISOTHERMAL NUCLEIC ACID DETECTION

PEPTIDE NUCLEIC ACIDS FOR SPATIOTEMPORAL CONTROL OF CRISPR-CAS BINDING

CYTOSOLIC DELIVERY OF GENOME EDITING TOOLS

VECTOR-FREE DELIVERY OF GENE EDITING PROTEINS AND COMPOSITIONS TO CELLS AND TISSUES

RNA-Guided Human Genome Engineering

METHODS AND COMPOSITIONS FOR MODIFYING SHADE AVOIDANCE IN PLANTS

GRAFTED PLANT FOR DELIVERY OF GENOME EDITING REAGENTS

NUCLEIC ACID NANOPARTICLES, PHARMACEUTICAL COMPOSITIONS, AND METHODS OF USE THEREOF

GENE EDITING FOR EXPRESSION OF FUNCTIONAL FACTOR VIII FOR THE TREATMENT OF HEMOPHILIA

METHODS FOR CONTROLLING MERISTEM SIZE FOR CROP IMPROVEMENT

ISOLATED CAS13 PROTEIN AND USE THEREOF

CRISPR-TRANSPOSON SYSTEMS FOR DNA MODIFICATION

CRISPR/CAS9-BASED REPRESSORS FOR SILENCING GENE TARGETS IN VIVO AND METHODS OF USE

Compositions and methods for making epigenetic modifications

TCRS SPECIFIC FOR MINOR HISTOCOMPATIBILITY (H) ANTIGEN HA-1 AND USES THEREOF

POLYOXYETHYLENE DERIVATIVES AND CONJUGATES THEREOF

HYPOIMMUNE CELLS

SGRNA AND CONSTRUCTING DUAL PIG MODEL OF SEVERE IMMUNODEFICIENCY AND LIVER INJURY AND USE THEREOF

METHODS OF TREATMENT WITH AMINOLEVULINIC ACID SYNTHASE 2 (ALAS2) MODULATORS

DIMERIZATION SCREENING ASSAYS

SYNTHETIC GENOMIC SAFE HARBORS AND METHODS THEREOF

ENGINEERED GUIDE RNA SCAFFOLDS AND METHODS THEROF FOR ENHANCED GENOME EDITING

RNA POLYMERASE III PROMOTERS AND METHODS OF USE

RNA-GUIDED CAS NUCLEASES AND USES THEREOF IN DIAGNOSTICS AND THERAPY

RNA GUIDED ERADICATION OF HERPES SIMPLEX TYPE I AND OTHER RELATED HUMAN HERPESVIRUSES

METHODS OF ENHANCING AND EXPEDITING EXPRESSION OF ANTIBODIES

SUPPRESSION OF PAIN BY GENE EDITING

EFFECTOR PROTEINS AND METHODS OF USE

CAS9 NICKASE-MEDIATED GENE EDITING

ENGINEERED MEGANUCLEASES SPECIFIC FOR RECOGNITION SEQUENCES IN THE HEPATITIS B VIRUS GENOME

ENGINEERED PROTEINS AND METHODS OF USE THEREOF

VECTOR MANUFACTURING PROCESSES

CRISPR-Cas9 Knock-out of SHP-1/2 to Reduce T cell Exhaustion in Adoptive Cell Therapy

Compositions and methods for enhancing adoptive T cell therapeutics

METHOD FOR PURIFYING A CATIONIC PROTEIN FRACTION AND FRACTION THUS OBTAINED

ADENO-ASSOCIATED VIRUS VIRIONS AND METHODS OF USE THEREOF

PD-1 GENE-EDITED TUMOR INFILTRATING LYMPHOCYTES AND USES OF SAME IN IMMUNOTHERAPY

Subject-Specific Tumor Inhibiting Cells and the Use Thereof

CRYOGENICALLY ARRAYABLE STABLE TRANSFECTION

CRISPR-Cas13 System, Kit and Method for Detecting SARS-CoV-2

Lipid Compositions and Methods for Delivery to Immune Cells

CRISPR TRANSIENT EXPRESSION CONSTRUCT (CTEC)

ADVANCED GENOME EDITING

AUTOMATED CELL PROCESSING METHODS, MODULES, INSTRUMENTS, AND SYSTEMS

GENE EDITING IN PRIMARY IMMUNE CELLS USING CELL PENETRATING CRISPR-CAS SYSTEM

DUPLEX-SPECIFIC DNASES

USE OF A FUSION PROTEIN FOR INDUCING GENETIC MODIFICATIONS BY TARGETED MEIOTIC RECOMBINATION

COMPOSITIONS, METHODS AND USES FOR TREATING CYSTIC FIBROSIS AND RELATED DISORDERS

GENE EDITING THERAPY FOR HIV INFECTION VIA DUAL TARGETING OF HIV GENOME AND CCR5

GENE EDITING SYSTEMS COMPRISING AN RNA GUIDE TARGETING TRANSTHYRETIN (TTR) AND USES THEREOF

NOVEL TARGETS FOR ENHANCING ANTI-TUMOR IMMUNITY

CHIMERIC TRANSGENIC IMMUNOGLOBULIN MICE WITH AN ALTERED HEAVY CHAIN LOCUS AND METHODS OF MAKING AND USING SAME

PAIRED-CELL PROFILING SYSTEMS FOR HIGH-THROUGHPUT SCREENING SYNCYTIUM FORMATION

SYSTEMS AND METHODS FOR REGULATING TARGET GENES

Degenerate CRISPR Cas13a crRNAs for Detection of Highly Variable RNA Sequences

COMPLEX FOR GENOME EDITING HAVING STABILITY AND FEW SIDE-EFFECTS, AND NUCLEIC ACID CODING SAME

VIRAL VECTOR PRODUCTION SYSTEMS, ENGINEERED CELLS FOR VIRAL VECTOR PRODUCTION, AND METHODS OF USE THEREOF

PRODUCTS AND METHODS FOR TREATMENT OF DYSTROPHIN-BASED MYOPATHIES USING CRISPR-CAS9 TO CORRECT DMD EXON DUPLICATIONS

Multi-Genome Editor Construct and Uses Thereof

ENGINEERED CELLS FOR PRODUCING OF THERAPEUTIC AGENTS TO BE DELIVERED BY A HYBRID BIOELECTRONIC DEVICE

DMP PROTEIN, ENCODING GENE AND USE THEREOF

PHAGE-DERIVED PARTICLES FOR IN SITU DELIVERY OF DNA PAYLOAD INTO C. ACNES POPULATION

GENE EDITING SYSTEMS COMPRISING AN RNA GUIDE TARGETING HYDROXYACID OXIDASE 1 (HAO1) AND USES THEREOF

COMPOSITIONS AND METHODS FOR MODULATING EXPRESSION OF FRATAXIN (FXN)

ENGINEERED GUIDE RNA FOR OPTIMIZED CRISPR/CAS12F1 SYSTEM AND USE THEREOF

COMPOSITIONS AND METHODS OF MODIFYING A PLANT GENOME TO PRODUCE A MS9, MS22, MS26, OR MS45 MALE-STERILE PLANT

Nucleic acid molecules encoding DNA modifying enzymes and active fragments and variants thereof and compositions comprising the same

ENGINEERED CLASS 2, TYPE V REPRESSOR SYSTEMS

HEAT-RESISTANT ENDONUCLEASE AND GENE EDITING SYSTEM MEDIATED BY HEAT-RESISTANT ENDONUCLEASE

CLEAVAGE-INACTIVE CAS12F1, CLEAVAGE-INACTIVE CAS12F1-BASED FUSION PROTEIN, CRISPR GENE-EDITING SYSTEM COMPRISING SAME, AND PREPARATION METHOD AND USE THEREOF

ENGINEERED STABLE NUCLEIC ACID-GUIDED NUCLEASES

COMPOSITIONS AND METHODS FOR MODULATING SECRETED FRIZZLED RECEPTOR PROTEIN 1 (SFRP1) GENE EXPRESSION

TRANSCRIPTION ACTIVATOR-LIKE EFFECTOR (TALE) - LYSINE-SPECIFIC DEMETHYLASE 1 (LSD1) FUSION PROTEINS

ENGINEERED CELLS FOR THERAPY

MODIFIED MAMMALIAN CELLS

GENE THERAPY FOR WET AGE-RELATED MACULAR DEGENERATION USING IPSC-DERIVED CELLS AS VECTORS

COMPOSITIONS AND METHODS FOR MODULATING EXPRESSION OF METHYL-CPG BINDING PROTEIN 2 (MECP2)

Precise Excisions of Portions of Exon 51 for Treatment of Duchenne Muscular Dystrophy

HBB-MODULATING COMPOSITIONS AND METHODS

SYNTHETIC EXOSOMES (SE) FOR CNS DELIVERY OF CRISPR FOR GENE EDITING IN BRAIN DISORDERS

GENETIC MODIFICATION OF HEPATOCYTES

COMPOSITIONS AND METHODS TO TRANSFECT, TEST, AND TREAT SKIN CELLS

CRISPR/CAS-RELATED METHODS AND COMPOSITIONS FOR IMPROVING TRANSPLANTATION

Detection of nucleic acid and non-nucleic acid target molecules

GENOME EDITING METHOD

METHODS FOR IMPROVED HOMOLOGOUS RECOMBINATION AND COMPOSITIONS THEREOF

METHODS FOR DELIVERING GENOME EDITING MOLECULES TO THE NUCLEUS OR CYTOSOL OF A CELL AND USES THEREOF

COMPOSITIONS AND METHODS FOR ADENO-ASSOCIATED VIRAL PRODUCTION

CRISPR/CAS SYSTEM AND METHOD FOR GENOME EDITING AND MODULATING TRANSCRIPTION

miRNA Switches for RNA-Triggered Control of RNA Interference

SYSTEM AND METHODS FOR INSERTION AND EDITING OF LARGE NUCLEIC ACID FRAGMENTS

GENE ASSEMBLY FROM OLIGONUCLEOTIDE POOLS

METHODS FOR MODULATING CAS-EFFECTOR ACTIVITY

METHODS AND COMPOSITIONS FOR MODULATING A GENOME

URACIL STABILIZING PROTEINS AND ACTIVE FRAGMENTS AND VARIANTS THEREOF AND METHODS OF USE

7-Morpholino-L,6-Naphthyridin-5-yl Derivatives and Pharmaceutical Compositions Thereof Useful as DNA-PK Inhibitor

METHODS FOR STRATIFYING SUBJECTS FOR FETAL HEMOGLOBIN REINDUCTION

COMPOSITIONS AND METHODS FOR ORGAN SPECIFIC DELIVERY OF NUCLEIC ACIDS

ENZYME-PORE CONSTRUCTS

Sample splitting for multiplexed detection of nucleic acids without amplification

COMPOSITIONS AND METHODS FOR INCREASING EFFICIENCY OF PRECISE EDITING REPAIR

Increasing Specificity for RNA-Guided Genome Editing

Cas9/RNA Complexes for Inducing Modifications of Target Endogenous Nucleic Acid Sequences in Nucleuses of Eukaryotic Cells

HOST FACTORS THAT ENHANCE VIRAL PRODUCTION VIA VIRALLY DRIVEN FITNESS-BASED CRISPR SCREENING

DNase I Variants, Compositions, Methods, and Kits

SYNTHETIC CAS PROTEINS

NON-VIRAL HOMOLOGY MEDIATED END JOINING

COMBINED TRANSPOSON-MEDIATED INTEGRATION AND TARGETED INTEGRATION OF NUCLEIC ACIDS INTO HOST CELLS

HUMAN IMMUNOGLOBULIN HEAVY CHAIN LONG CDR3 TRANSGENE CONSTRUCTS AND USES THEREOF

7-Morpholino-1,6-Naphthyridin-5-yl Derivatives and Pharmaceutical Compositions Thereof Useful as DNA-PK Inhibitor

COMPOSITION FOR PREVENTING OR TREATING PROGERIA AND NATURAL AGING THROUGH GENE EDITING

CD-90 Targeted Lipid Nanoparticles

COMPOSITIONS AND METHODS FOR TREATING ACUTE MYELOID LEUKEMIA

TREATMENT OF RETINITIS PIGMENTOSA USING ENGINEERED MEGANUCLEASES

COMPOSITIONS AND METHODS FOR CD123 MODIFICATION

COMPOSITIONS COMPRISING NULLOMERS AND METHODS OF USING THE SAME FOR CANCER DETECTION AND DIAGNOSIS

METHODS FOR ANALYZING NUCLEIC ACID SEQUENCES

METHODS AND COMPOSITIONS FOR SEQUENCING LIBRARY NORMALIZATION

RECOMBINANT CELL AND METHOD FOR PRODUCING ENDOGENOUS POLYPEPTIDE

CRISPR-CAS3 SYSTEMS FOR TARGETED GENOME ENGINEERING

CONTROLLED GENE EXPRESSION METHODS AND MEANS

ENGINEERED TARGET SPECIFIC NUCLEASES

MATERIALS AND METHODS FOR TREATMENT OF GLYCOGEN STORAGE DISEASE TYPE 1A

METHODS AND COMPOSITIONS FOR PRIME EDITING NUCLEOTIDE SEQUENCES

HOMOLOGOUS RECOMBINATION VIA TRANSCRIPTIONAL ACTIVATION

EXPRESSION VECTORS, BACTERIAL SEQUENCE-FREE VECTORS, AND METHODS OF MAKING AND USING THE SAME

MODIFIED ORTHOPOXVIRUS VECTORS

TRANSGENIC CORN EVENT ZM_CSM63715 AND METHODS FOR DETECTION AND USES THEREOF

TOXIN-FREE ALOE AND METHODS OF MAKING SAME

QPT GENE ENGINEERED PLANT CELL AND USING METHOD OF THE SAME

CHLOROPLAST CYTOSINE BASE EDITORS AND MITOCHONDRIA CYTOSINE BASE EDITORS IN PLANTS

SEMI-RATIONAL GENOME EVOLUTION ENGINEERING METHOD FOR PLANTS

COMPOSITIONS FOR GENOME EDITING

RNA-TRIGGERED PROTEIN CLEAVAGE AND APPLICATIONS BY THE CRISPR CAS7-11-CSX29 COMPLEX

TRANSCRIPTIONAL PROGRAMMING IN A BACTEROIDES CONSORTIUM

SITE-SPECIFIC GENOME MODIFICATION TECHNOLOGY

MODIFIED NUCLEIC ACIDS, HYBRID GUIDE RNAS, AND USES THEREOF

TUNING CRISPR/CAS9 ACTIVITY WITH CHEMICALLY MODIFIED NUCLEOTIDE SUBSTITUTIONS

DNASE 1-LIKE 2 ENGINEERED FOR MANUFACTURING AND USE IN THERAPY

RATIONALLY-DESIGNED MEGANUCLEASES WITH ALTERED SEQUENCE SPECIFICITY AND DNA-BINDING AFFINITY

Engineered nucleic acid-guided nucleases

FUSION MOLECULES OF RATIONALLY-DESIGNED DNA-BINDING PROTEINS AND EFFECTOR DOMAINS

METHODS AND COMPOSITIONS FOR IN VIVO GENE EDITING BASED CELL-TYPE-SPECIFIC CELLULAR ENGINEERING

COMPOSITIONS AND METHODS FOR EFFICIENT GENOME EDITING

METHODS FOR EXPANDING REGULATORY T CELLS

Programmed Cell Death Protein 1 (PD1) Compositions and Methods for Cell-Based Therapy